Ultroser G serum substitute產品介紹：
Ultroser G血清替代品可以在細胞培養基中成功替代FCS(胎牛血清)。Ultroser G血清替代品設計用于依賴貼壁細胞的體外培養。已在羊膜液細胞原代培養中測試過，旨在確認其核型分析能力。Ultroser G血清替代品通過CE標記注冊。
Ultroser G血清替代品通過一系列質量測試，包括PH、蛋白質濃度、無菌控制、細菌和真菌、牛病毒（BHV1-DVB/MM,紅細胞吸附）、支原體、Hep G2細胞增殖能力、核型分析等。

Ultroser G serum substitute產品特性：

半固定成份確保批次間可重現性、

低蛋白含量

方便使用和保藏

Ultroser G血清替代品濃度是胎牛血清濃度的5倍（2%血清替代品相當于10%胎牛血清）

Ultroser G serum substitute英文簡述：
Ultroser G serum substitute can successfully replace FCS (fetal calf serum) in cell culture medium. It is designed for the in vitro culture of anchorage-dependent cells. It is specially tested as the primary culture from amniotic liquid cells and is designed to confirm their ability for karyotyping. Ultroser G serum substitute is CE mark-certified.
Ultroser G serum substitute has a concentration five times higher than fetal calf serum (2 % of reconstituted Ultroser G serum substitute is equivalent to 10%  fetal calf serum in the basal medium).

Quality Control Tests
Tests usually performed on Ultroser G serum substitute are: 
● Physicochemical parameters pH 
● Protein concentration 
● Sterility control 
● Bacteria & Fungi 
● Bovine viruses (BHV1-DVB/MM, hemadsorbents) 
● Proliferation capacity on Hep G2
● Mycoplasma
● Karyotyping